Mesterolone

DB13587InvestigationalSmall molecule

Mesterolone is an anabolic steroid indicated in the treatment of low testosterone, hypogonadism, oligozoospermia, and Leydig cell failure. Mesterolone is a synthetic anabolic-androgenic steroid (AAS) and derivative of dihydrotestosterone (DHT).

Mechanism: Pharmacologically active on Androgen receptor
Curator reviewed
Formula / weight: C₂₀H₃₂O₂ · 304.4669 g/mol (avg)
Code names: NSC-75054 · SH-723

Resolves to

Compound

UNII0SRQ75X9I9CAS1424-00-6ChEMBLCHEMBL258918ChEBI135293PubChem15020

Clinical / RWD

RxNorm6781ATCG03BB01

Structure

InChIKeyUXYRZJKIQKRJCF-TZPFWLJSSA-NSMILES[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C[C@H](C)[C@]12C

Targets

P10275AR

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

174Drug interactionsStructured to mechanism, not free text

4Structured indicationsCondition, population, route and combination as fields, not prose

4ContraindicationsEach with its own population and attribute set

13Marketed productsAcross 6 countries and 7 labellers

1ATC codeIncluding every combination product, plus 12 drug categories

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mesterolone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account